Logo image
Attributable mortality of nosocomial candidemia, revisited
Journal article   Open access   Peer reviewed

Attributable mortality of nosocomial candidemia, revisited

Olafur Gudlaugsson, Shane Gillespie, Kathleen Lee, Jeff Vande Berg, Jianfang Hu, Shawn Messer, Loreen Herwaldt, Michael Pfaller and Daniel Diekema
Clinical infectious diseases, Vol.37(9), pp.1172-1177
11/01/2003
DOI: 10.1086/378745
PMID: 14557960
url
https://doi.org/10.1086/378745View
Published (Version of record) Open Access

Abstract

We reexamined the attributable mortality of nosocomial candidemia 15 years after a retrospective cohort study performed at our hospital demonstrated an attributable mortality of 38%. For all episodes of nosocomial candidemia between 1 July 1997 and 30 June 2001, we matched control patients with case patients by age, sex, date of hospital admission, underlying disease(s), length of time at risk, and surgical procedure(s). We analyzed 108 matched pairs. There were no statistically significant differences in age, sex, underlying disease(s), time at risk, surgical procedure, or vital signs at admission between cases and controls. The crude mortality among case patients was 61% (66 of 108 patients), compared with 12% (13 of 108) among control patients, for an attributable mortality of 49% (95% CI, 38%-60%). Nosocomial candidemia is still associated with an extremely high crude and attributable mortality--much higher than that expected from underlying disease alone.
Antifungal Agents - pharmacology Length of Stay Fluconazole - pharmacology Age Factors Humans Middle Aged Cross Infection - mortality Candidiasis - mortality Male Survival Rate Fungemia - mortality Microbial Sensitivity Tests Candida - classification Sex Factors Female Retrospective Studies Candida - drug effects Cohort Studies

Details

Metrics

Logo image